CHD9 and neuroblastoma: So far, CHD9 mutations have not been reported in previous Next Generation Sequencing studies probably because in our study we used a restricted and homogeneous sub-set of aggressive neuroblastoma and because we profiled most of the tumors by DT-seq reaching coverage higher than 700x.